AKTX

Akari Therapeutics
AKTX

15 hedge funds and large institutions have $644K invested in Akari Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, 3 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$227K
2
+$99.9K
3
+$8.57K
4
EWA
EverSource Wealth Advisors
Alabama
+$5.52K
5
UBS Group
UBS Group
Switzerland
+$2.72K

Top Sellers

1
-$31.4K
2
-$1.22K
3
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$210K
2
$171K
3
$92.7K
4
$73.3K
5
$27.7K
6
$21.5K
7
$20.4K
8
$11.7K
9
$7.96K
10
$5.12K
11
$2.52K
12
$175
13
$59
14
$5
15
$4